Quantum technology firm EigenQ to go public in $3 billion SPAC deal

Summary

Quantum technology company EigenQ plans to go public through a merger with Silicon Valley Acquisition Corp. (SVAQ) in a deal valuing the combined company at approximately $3 billion. The company develops quantum security, communications, sensing and computing technologies, with a focus on post-quantum cybersecurity solutions for enterprise and government customers.

SILICON VALLEY, June 17, 2026 — EigenQ Inc. has entered into a definitive business combination agreement with special purpose acquisition company Silicon Valley Acquisition Corp. (NASDAQ: SVAQ), paving the way for the quantum technology company to become publicly listed.

The transaction values EigenQ at a pro forma enterprise value of approximately $3 billion. Upon completion of the merger, the combined company is expected to operate as EigenQ and list on the Nasdaq under the ticker symbol “EIGQ.”

The deal is supported by approximately $215 million currently held in Silicon Valley Acquisition Corp.’s trust account before shareholder redemptions and transaction expenses.

EigenQ develops technologies across several quantum-focused sectors, including quantum security, quantum communications, quantum sensing, quantum artificial intelligence and quantum computing. The company is particularly focused on post-quantum cybersecurity solutions designed to protect digital infrastructure against future advances in quantum computing.

A key area of focus is post-quantum cryptography, which aims to safeguard sensitive information against potential threats posed by future quantum computers capable of breaking some of today’s widely used encryption standards.

Chief Executive Officer Prof. Jesse Van Griensven Thé said the public listing would provide additional resources to accelerate commercialization and expand the company’s market presence.

The company has developed solutions designed to align with emerging post-quantum security standards and regulatory requirements. Growing interest in quantum-safe security has been driven by efforts from governments and standards organizations to prepare critical systems for future quantum computing capabilities.

EigenQ has also established strategic relationships with technology and distribution partners including Hewlett Packard Enterprise (HPE), AMD, WNC and TD SYNNEX to support deployment, manufacturing and channel expansion efforts.

The merger has been unanimously approved by the boards of both companies and is expected to close in the fourth quarter of 2026, subject to shareholder approval, regulatory review and other customary closing conditions.

Why this matters

• Growing quantum security market: Organizations are increasingly evaluating post-quantum cybersecurity technologies as governments and standards bodies prepare for future quantum computing risks.
• Public market access: The transaction provides EigenQ with access to capital markets to support product development and commercialization.
• Industry partnerships: Relationships with major technology and distribution companies could help accelerate market adoption of quantum-security solutions.
• SPAC activity in emerging technologies: The deal highlights continued investor interest in quantum computing and cybersecurity businesses despite a slower overall SPAC market.

FAQs

Q1: What is the value of the EigenQ-SPAC transaction?

The merger values EigenQ at a pro forma enterprise value of approximately $3 billion.

Q2: Which company is EigenQ merging with?

EigenQ is combining with Silicon Valley Acquisition Corp. (NASDAQ: SVAQ), a special purpose acquisition company.

Q3: What will the combined company trade under?

The company expects to list on Nasdaq under the ticker symbol EIGQ.

Q4: What does EigenQ do?

EigenQ develops technologies focused on quantum security, communications, sensing, artificial intelligence and computing applications.

Q5: When is the transaction expected to close?

The companies expect the merger to close during the fourth quarter of 2026, subject to approvals and customary conditions.